Skip to product information
1 of 2

KSR2 Recombinant Rabbit mAb (S-2839-69)

KSR2 Recombinant Rabbit mAb (S-2839-69)

Catalog Number: S0B60819 Application: WB Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen KSR2
Synonyms Kinase suppressor of Ras 2
Immunogen Synthetic Peptide
Location Cytoplasm
Accession Q6VAB6
Clone Number S-2839-69
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu
Positive Sample PLC transfected with KSR2 protein, mouse brain
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu, Ms

Background

KSR2 (kinase suppressor of Ras 2) is an intracellular scaffold protein belonging to the KSR family, whose defining feature is a pseudokinase domain that lacks the key catalytic residues and, although highly similar to protein kinases, does not possess conventional catalytic activity. The classical function of KSR2 is to serve as a molecular scaffold of the Ras–Raf–MEK–ERK signaling pathway, promoting MEK phosphorylation and cascade activation by directly binding RAF and MEK; it is also regulated by calcineurin to participate in calcium-mediated ERK signaling, and through interaction with AMPK it regulates energy metabolic processes such as glucose uptake and fatty acid oxidation. At the human genetics level, a 2013 study published in Cell sequenced 2,101 patients with severe early-onset obesity and 1,536 controls, identifying multiple rare KSR2 variants that disrupt Raf-MEK-ERK signaling and impair cellular fatty acid and glucose oxidation; mutation carriers exhibited childhood hyperphagia, reduced basal metabolic rate, bradycardia, and severe insulin resistance, establishing KSR2 as an important regulator of human energy intake, energy expenditure, and substrate utilization. In the field of oncology, a 2025 study further revealed that KSR2 is preferentially expressed in ASCL1-subtype small cell lung cancer and, through interaction with ERK, drives the self-renewal and clonogenic capacity of tumor-initiating cells, suggesting its value as a potential therapeutic target for this subtype.

Picture

Western Blot

WB result of KSR2 Recombinant Rabbit mAb
Primary antibody: KSR2 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: PLC transfected with KSR2 protein whole cell lysate 20 µg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 108 kDa
Observed MW: 125 kDa
This blot was developed with high sensitivity substrate

WB result of KSR2 Recombinant Rabbit mAb
Primary antibody: KSR2 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: mouse brain lysate 20 µg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 108 kDa
Observed MW: 125 kDa
This blot was developed with high sensitivity substrate